VANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USDVANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USDVANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USD

VANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USD

No trades
See on Supercharts

Key stats

Assets under management (AUM)
‪4.91 M‬GBP
Fund flows (1Y)
‪485.95 K‬GBP
Dividend yield (indicated)
Discount/Premium to NAV
1.2%

About VANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USD

Issuer
Van Eck Associates Corp.
Brand
VanEck
Expense ratio
0.55%
Home page
Inception date
Dec 2, 2022
Index tracked
MVIS Global Bionic Healthcare ESG Index - Benchmark TR Net
Management style
Passive
ISIN
IE0005TF96I9
Functions as an open-end investment fund

Classification

Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Weighting scheme
Market cap
Selection criteria
Market cap

Returns

1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund

As of May 2, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.92%
Health Technology95.30%
Electronic Technology2.47%
Distribution Services2.15%
Bonds, Cash & Other0.08%
Cash0.08%
Stock breakdown by region
4%82%11%1%
North America82.84%
Europe11.47%
Oceania4.42%
Asia1.27%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends

Dividend payout history

Assets under management (AUM)

Fund Flows